TR201110202A2 - Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids - Google Patents

Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids

Info

Publication number
TR201110202A2
TR201110202A2 TR2011/10202A TR201110202A TR201110202A2 TR 201110202 A2 TR201110202 A2 TR 201110202A2 TR 2011/10202 A TR2011/10202 A TR 2011/10202A TR 201110202 A TR201110202 A TR 201110202A TR 201110202 A2 TR201110202 A2 TR 201110202A2
Authority
TR
Turkey
Prior art keywords
hepatitis
aids
treatment
antiretroviral
pharmaceuticals
Prior art date
Application number
TR2011/10202A
Other languages
Turkish (tr)
Inventor
Erten Başaran Fatma
Original Assignee
Erten Başaran Fatma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erten Başaran Fatma filed Critical Erten Başaran Fatma
Priority to TR2011/10202A priority Critical patent/TR201110202A2/en
Publication of TR201110202A2 publication Critical patent/TR201110202A2/en

Links

Abstract

Mevcut buluş, hepatit B enfeksiyonu ve/veya AIDS'in tedavisinde kullanılmak üzere; antiretroviral aktiviteye sahip farmasötik olarak kabul edilebilir uygun etken madde/leri veya tuzlarını veya ön ilaçlarını içeren farmasötik bileşimler ile ilgilidir.The present invention is for use in the treatment of hepatitis B infection and / or AIDS; The present invention relates to pharmaceutical compositions comprising suitable pharmaceutically acceptable active substances (s) or salts or prodrugs having antiretroviral activity.

TR2011/10202A 2011-10-14 2011-10-14 Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids TR201110202A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/10202A TR201110202A2 (en) 2011-10-14 2011-10-14 Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/10202A TR201110202A2 (en) 2011-10-14 2011-10-14 Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids

Publications (1)

Publication Number Publication Date
TR201110202A2 true TR201110202A2 (en) 2012-06-21

Family

ID=47003797

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/10202A TR201110202A2 (en) 2011-10-14 2011-10-14 Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids

Country Status (1)

Country Link
TR (1) TR201110202A2 (en)

Similar Documents

Publication Publication Date Title
MX2013005478A (en) Antiviral condensed heterocyclic compounds.
EA201591027A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
EA201391519A1 (en) 2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF THEIR USE FOR THE TREATMENT OF VIRAL DISEASES
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
BR112015016315A2 (en) fluoro- [1,3] oxazine as bace1 inhibitors
EA201301158A1 (en) ANTI-VIRUS COMPOUNDS
EA201290575A1 (en) FLAVIVIRIDAE VIRUS INHIBITORS
MX2016004492A (en) Inhibitors of human immunodeficiency virus replication.
EA201391098A1 (en) C-28-AMINES C-3-MODIFIED BETULINIC DERIVATIVE DERIVATIVES AS AN HIV INHIBITORS INHIBITORS
GEP201706698B (en) Inhibitors of influenza viruses replication
BR112015007366A2 (en) acylaminopyrimidine derivatives for the treatment of viral infections and other diseases
PH12015501156A1 (en) Pharmaceutical compositions
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
BR112012017705A2 (en) 3,4-diarylpyrazole sulfonamide derivatives as protein kinase inhibitors
NZ628408A (en) Ingenol derivatives in reactivation of latent hiv virus
EA201300132A1 (en) PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT AND PREVENTION OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV
MA32841B1 (en) Compounds of cyclondica dipseibeptides and their use as drugs
EA201290852A1 (en) COMBINED THERAPY, INCLUDING ANTAGONIST CCR5, HIV-1 PROTEASE INHIBITOR AND PHARMACOKINETIC AMPLIFIER
IN2011CH03893A (en)
TR201110202A2 (en) Antiretroviral pharmaceuticals in the treatment of hepatitis b and/or aids
WO2014140680A8 (en) Dosing regimen for use of celgosivir as an antiviral therapeutic for dengue virus infection
EA201892004A1 (en) ANTIVIRAL AGENTS FOR THE TREATMENT OF HEPATITIS B
PL401956A1 (en) Derivatives of 1,2,4-triazole-5-thione, and their use
TR201201022A2 (en) Pharmaceutical compositions for use in the symptomatic and / or therapeutic treatment of lung diseases, liver diseases and various infections.